Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Smart Quote
Neuland Laboratories Ltd.
BSE Code 524558
ISIN Demat INE794A01010
Book Value (Rs) 1182.30
NSE Code NEULANDLAB
Dividend Yield % 0.10
Market Cap(Rs Mn) 157884.61
TTM PE(x) 60.86
TTM EPS(Rs) 202.20
Face Value (Rs) 10  
 
Jul 11, 2025
Last Price  12306.00  
Prev.Close  11902.05  
Net Change  403.95  
52-Week High  18089.55  
Open  11949.80  
High  12377.00  
Low   11752.50
52-Week Low  7900.00  
 
1 D | 1 M | 3 M | 1 Y
Stock Return Performance (in %) M Cap Sales
  Company Name 1W 1M 6M 1Y
Neuland Laboratories   3   -10   -6   52
Sun Pharma Inds.   0   -1   -4   6
Divi's Lab   -1   2   19   49
Cipla   -2   -2   3   -1
Torrent Pharma   -2   3   2   12
BSE HC   -1   1   4   15
 Company Name 1W 1M 6M 1Y
Neuland Laboratories   3   -10   -6   52
Dr. Reddy's Lab   -4   -7   -6   -5
Sun Pharma Inds.   0   -1   -4   6
Cipla   -2   -2   3   -1
Lupin   -4   -7   -12   4
BSE HC   -1   1   4   15
Sensex   -1   0   8   3
 
News
More
Key Maket Ratio
Latest EPS 202.20 MktCap/Sales 10.69
Latest CEPS 253   P/CEPS 49
Price / BV 10.41 Price / Sales 0.83
EV / EBIDTA 45.70 EV / Sales 10.61
Div Yield % 0.10    
Results Standalone Consolidated
TTM Latest 4 Quarters Quarter on Quarter
Particulars Prev.TTM
Net Sales  15586 
PBDIT 4619 
PAT 2996 
EPS 234 
Mar 2025Dec 2024Sep 2024Jun 2024
3284398031084396
5088646131238
2771014320983
22792577
Mar 2024  Var %
3850  -15 
1068  -52 
676  -59 
53  -59 
TTM Latest 4 Quarters Quarter on Quarter
Particulars Prev.TTM
Net Sales  15586 
PBDIT 4626 
PAT 3001 
EPS 234 
Mar 2025Dec 2024Sep 2024Jun 2024
3284398031084396
5118666221234
2781016328979
22792676
Mar 2024  Var %
3850  -15 
1069  -52 
676  -59 
53  -59 
MF Holding Details
 
Competitors
 Peer CompaniesLTP%Chg
Glenmark Pharma 2181.55 14.51
Astrazeneca Pharma I 9237.05 1.4
Procter&Gamble Healt 5777.05 1.65
Alkem Laboratories 4806.95 1.53
Wockhardt 1756.75 3.51